Kendle

Sally Osmond has been named vice president of Europe, Middle East and Africa at Kendle. Ms. Osmond will provide senior-level leadership for the company’s Phase II-IV clinical operations throughout these regions, driving overall corporate performance and customer focus. Ms. Osmond has more than 30 years of clinical trial management and operations leadership experience and will be based in the company’s Camberley, UK office. She reports to senior vice president and chief operating officer, Stephen Cutler, Ph.D.

“Success in Europe, Middle East and Africa is essential to Kendle’s continued growth as a top-tier global CRO,” said Dr. Cutler. “We look forward to Sally’s leadership as we continue to focus on broadening and deepening our capabilities in the region and across our global footprint to strengthen our position as a strategic partner.”

Ms. Osmond’s experience includes serving in multiple executive roles at multi-national CROs such as Quintiles, where she most recently served as vice president and business leader for Quality in Clinical Research. Other positions she held at Quintiles include vice president and global head, project coordination center; vice president, late phase operations; late phase head of project coordination; European head of late phase operations; customer program director; and group project director for Internal Medicine. Prior to joining Quintiles, she was chief operating officer at UCTi, a global central lab.